Non-small cell lung cancer: current treatment and future advances - sprookjes - yvandenbroek - TriplyDB

Non-small cell lung cancer: current treatment and future advances

Non-small cell lung cancer: current treatment and future advances

http://www.wikidata.org/entity/Q26740333

about

USP22 Induces Cisplatin Resistance in Lung Adenocarcinoma by Regulating γH2AX-Mediated DNA Damage Repair and Ku70/Bax-Mediated Apoptosis Predictive assessment in pharmacogenetics of Glutathione S-transferases genes on efficacy of platinum-based chemotherapy in non-small cell lung cancer patients.Prognostic value of plasma EGFR ctDNA in NSCLC patients treated with EGFR-TKIs Prognostic value of wingless-type proteins in non-small cell lung cancer patients: a meta-analysis.A meta-analysis of efficacy and safety of antibodies targeting PD-1/PD-L1 in treatment of advanced nonsmall cell lung cancer.Circulating Cell Free Tumor DNA Detection as a Routine Tool forLung Cancer Patient Management.Comparative effectiveness of combined therapy inhibiting EGFR and VEGF pathways in patients with advanced non-small-cell lung cancer: a meta-analysis of 16 phase II/III randomized trials Prognostic and predictive values of CDK1 and MAD2L1 in lung adenocarcinoma.Genome-scale analysis identifies NEK2, DLGAP5 and ECT2 as promising diagnostic and prognostic biomarkers in human lung cancer Novel nanoparticulate systems for lung cancer therapy: an updated review.Current status of research and treatment for non-small cell lung cancer in never-smoking females.Targeting P-glycoprotein: Investigation of piperine analogs for overcoming drug resistance in cancer.Immunoproteasome deficiency in non-small cell lung cancer and its relevance to immunotherapy.Novel Mutations of the CHRNA3 Gene in Non-Small Cell Lung Cancer in an Iranian Population Lung cancer requires multidisciplinary treatment to improve patient survival: A case report.An Agent-Based Clustering Approach for Gene Selection in Gene Expression Microarray.Neuropeptide gastrin-releasing peptide induces PI3K/reactive oxygen species-dependent migration in lung adenocarcinoma cells.Immunotherapy for Non-small-cell Lung Cancer: Current Status and Future Obstacles.Overexpression of RAD51B predicts a preferable prognosis for non-small cell lung cancer patients.miR‑185 inhibits non‑small cell lung cancer cell proliferation and invasion through targeting of SOX9 and regulation of Wnt signaling.Actin Filament-Associated Protein 1-Like 1 Mediates Proliferation and Survival in Non-Small Cell Lung Cancer Cells.Cell death-based treatment of lung adenocarcinoma.Incorporation of Biological Knowledge Into the Study of Gene-Environment Interactions.PSCA and MUC1 in non-small-cell lung cancer as targets of chimeric antigen receptor T cells.Cytotoxic action of methylquercetins in human lung adenocarcinoma cells.Intraoperative Molecular Imaging in Lung Cancer: The State of the Art and the Future.Celecoxib-erlotinib combination treatment enhances radiosensitivity in A549 human lung cancer cell.Cetuximab combined with natural killer cells therapy: an alternative to chemoradiotherapy for patients with advanced non-small cell lung cancer (NSCLC).Homoharringtonine induced immune alteration for an Efficient Anti-tumor Response in Mouse Models of Non-small Cell Lung Adenocarcinoma Expressing Kras Mutation.Downregulation of Glutathione S-transferase A1 suppressed tumor growth and induced cell apoptosis in A549 cell line.Effect of FAM196B in human lung adenocarcinoma.High Sensitive and Non-invasive ctDNAs Sequencing Facilitate Clinical Diagnosis And Clinical Guidance of Non-small Cell Lung Cancer Patient: A Time Course Study Cryptotanshinone Induces Cell Cycle Arrest and Apoptosis of NSCLC Cells through the PI3K/Akt/GSK-3β Pathway contributes to the metastasis phenotype in human non-small-cell lung cancer cells possibly through the interaction with and Utilizing Stereotactic Spine Navigation for Posterior Partial Vertebrectomy in an En Bloc Resection of a Superior Pulmonary Sulcus Tumor Invading the Thoracic Vertebrae: A Technical Note

P2860

Q33696463-62B7F5AB-575A-44D6-B581-64D6AEA3D861 Q33752840-17EC35A0-456B-4EEE-93B9-26E21BCC1DB6 Q36319739-7A52DE1C-A997-453B-8821-7890D62A3C22 Q37227295-6C070956-2114-40D8-8814-A13D4BA3A68B Q37552085-2D2CF90B-CA4F-4A40-8A83-BF680E68B4E4 Q37690677-A192E3D6-775D-41DD-9CC4-AA66D4D7033B Q37701719-7EF3AF0D-41D2-4EBE-9EF2-834F0029DF93 Q37709125-BD204424-2F1E-4736-8722-FFDA8552E72E Q38624921-4C8714A5-6B41-43DC-9EBE-CFF6005A6440 Q38762917-125C665D-8892-4A2E-BE19-D6D901DEEEC2 Q39298725-F2092168-43C3-4F0F-AA42-CE007126D49E Q41368134-307892EC-6B41-4F68-8050-B28D42247FEF Q41428789-69E4C7DD-5640-4DF9-84E5-8EFA6BE47983 Q41461493-433A86FA-5DC0-4A2D-999A-A3D702B530C5 Q41597415-AC08C567-5291-4476-A9B8-9880D236AB43 Q45948152-258E28BD-924C-4163-AA71-A9F2EDF05F6C Q46395036-A092297C-C21E-4E75-A832-0ACCCD3E8839 Q47093855-3BF78F6D-3F92-4847-B413-4FAC5BB4DD2C Q47105602-593EC303-4BA0-4B86-B76F-B31A36CFC163 Q47401320-4FE6F41F-6201-4163-950E-99143BF18E29 Q47660171-BE10EE77-3335-49E5-9077-BA44F6C67BD9 Q47711273-BFA94D12-2747-4D3F-A95B-F8DD507A8080 Q47864609-941E4AC0-EBF0-4619-9AEF-05CA379A1BBD Q47920923-B3A402E2-E477-4D3B-9914-88A300881574 Q49320631-6A41FFD5-8073-474C-9D93-89CDEC5C144F Q49341132-C2643437-199E-4877-963D-24A01925A1CA Q52782809-5525D752-022B-4424-BFBC-CCE472127E6F Q55005404-6D34927F-116A-41E1-A006-8A082C3F6E3D Q55079595-CE08AB34-0686-46B2-9510-92B0D5634427 Q55282389-6606D6E4-F2C1-4051-BD26-2CC0CCDF2969 Q55714890-C85780FB-AD02-4A90-B056-196A4B084F3A Q58693928-BFC0B94F-3E4F-46CF-96AE-6AC0A2CBE146 Q58742499-59E2E21F-31CC-4254-B7EE-29A0007FB098 Q58781894-FCBC48F9-22E7-4159-A15F-9D7C9B68E6A0 Q59128974-638E9775-27EE-400C-9073-70D4D590BF71

P2860

Non-small cell lung cancer: current treatment and future advances

http://www.wikidata.org/entity/Q26740333

description

2016 nî lūn-bûn

@nan

2016 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

name

Non-small cell lung cancer: current treatment and future advances

@ast

Non-small cell lung cancer: current treatment and future advances

@en

Non-small cell lung cancer: current treatment and future advances

@nl

type

label

Non-small cell lung cancer: current treatment and future advances

@ast

Non-small cell lung cancer: current treatment and future advances

@en

Non-small cell lung cancer: current treatment and future advances

@nl

prefLabel

Non-small cell lung cancer: current treatment and future advances

@ast

Non-small cell lung cancer: current treatment and future advances

@en

Non-small cell lung cancer: current treatment and future advances

@nl

P1433

Q26740333-F0C92954-251F-4A28-A7DE-686F0A3BF9A8

P1476

Q26740333-C2D40A18-0145-4F00-A8B3-F2700D583741

P2093

Q26740333-C4F31C77-2E29-4FED-99F4-D05B8BE1467E

P2860

Q26740333-003B7D42-3532-4D7E-BE80-60DA01BF4C8C

Q26740333-0041DC55-B32E-4F9B-AC5B-B601648EEFD6

Q26740333-0098A74E-D577-42FD-9F1F-B83E95BF4701

Q26740333-00AF864A-90FA-4D02-8442-C17259A19A53

Q26740333-03338093-A906-4C00-9704-1DDE9845665C

Q26740333-03A45C88-F123-4F4B-BBE2-BE92B61B104C

Q26740333-0B4B83D6-BF4C-46FC-9FD2-EB82BE1E401A

Q26740333-0B9B9DBF-41B4-48D6-9BE2-DA1E4BEE7480

Q26740333-0E47D117-095D-4326-AF52-7546F9C5E3CD

Q26740333-100DBFE5-5390-4118-BDC4-A785B6451DC1

P304

Q26740333-E66D0881-2178-4C28-A627-BD1F7B7AFB06

P31

Q26740333-49651429-A782-4BDF-8120-768F0FD18B82

P356

Q26740333-4B2723A9-2660-4504-AA3D-54B3188EB74C

P407

Q26740333-1C81A035-18D1-4477-AEAC-086E99B23EF6

P433

Q26740333-D10FD049-4987-4582-AD8C-3503A0E414B5

P478

Q26740333-4ACC9046-9A52-4DE4-A74F-5B7863251718

P50

Q26740333-8A5B07DC-7928-4117-A82B-7D95F290ECC9

P577

Q26740333-F8B72F0C-1154-4437-B2A1-4C2EA2B65E83

P698

Q26740333-E6177CDA-33C5-4D40-8875-87B31DA2E772

P932

Q26740333-526B7B34-D265-4DFF-8DA0-0D6585DC19AA

P356

TLCR.2016.06.07

P1433

Translational lung cancer research

P1476

Non-small cell lung cancer: current treatment and future advances

@en

P2093

Cecilia Zappa

http://www.w3.org/2001/XMLSchema#string

P2860

An epidemiologic study of the role of chrysotile asbestos fiber dimensions in determining respiratory disease risk in exposed workers

Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

Comparison of aspects of smoking among the four histological types of lung cancer

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

K-Ras(G12C) inhibitors allosterically control GTP affinity and effector interactions

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer.

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer.

Frequency and distinctive spectrum of KRAS mutations in never smokers with lung adenocarcinoma.

P304

288-300

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.21037/TLCR.2016.06.07

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27413711

http://www.w3.org/2001/XMLSchema#string

P932

4931124

http://www.w3.org/2001/XMLSchema#string